Top Institutions in Ophthalmology, Retinal Diseases
Leading institutions employ advanced clinical trials, molecular biology research, and imaging technologies such as optical coherence tomography (OCT) to investigate the efficacy and mechanisms of combined Ang-2 and VEGF inhibition in retinal vascular diseases.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is internationally recognized for its pioneering clinical research in retinal diseases and anti-VEGF therapies, with extensive experience in clinical trials evaluating novel agents targeting vascular pathways including Ang-2.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear has a strong translational research program bridging molecular mechanisms of retinal vascular disease with clinical applications, including pioneering work on the Ang-TIE pathway and novel biologics.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive research in retinal vascular diseases and has contributed significantly to understanding the pathophysiology of VEGF and angiopoietin signaling in ocular neovascularization.
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF has a robust clinical and laboratory research program focused on retinal vascular diseases, including innovative studies on anti-VEGF agents and emerging therapies targeting angiopoietin pathways.
-
#5
Moorfields Eye Hospital
London, N/A
Moorfields is a global leader in retinal disease research and clinical trials, with significant contributions to the development and evaluation of anti-VEGF and Ang-2 targeted therapies.
